Cargando…
Future perspectives of anticholinergics for the treatment of asthma in adults and children
Despite major advances in therapeutic interventions and the availability of detailed treatment guidelines, a high proportion of patients with symptomatic asthma remain uncontrolled. Asthma management is largely guided by the Global Initiative for Asthma (GINA) strategy and is based on a backbone of...
Autores principales: | Buhl, Roland, Hamelmann, Eckard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422409/ https://www.ncbi.nlm.nih.gov/pubmed/30936709 http://dx.doi.org/10.2147/TCRM.S180890 |
Ejemplares similares
-
Long-acting muscarinic antagonists for the treatment of asthma in children—a new kid in town
por: Hamelmann, Eckard
Publicado: (2018) -
Asthma exacerbations and worsenings in patients aged 1–75 years with add-on tiotropium treatment
por: Mark FitzGerald, J., et al.
Publicado: (2020) -
Tiotropium in asthma: back to the future of anticholinergic treatment
por: Bonini, Matteo, et al.
Publicado: (2017) -
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management
por: Kaplan, Alan, et al.
Publicado: (2020) -
Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium
por: Hamelmann, Eckard
Publicado: (2018)